19/09/2025, Friday05:33
flag
Yeni Şafak

EDITION   :

TRTRENENARARFRFRRURUURUR

BioNTech, Turkey in talks on opening research center in country

Kübra Nur Eyüpoğlu
07:47, 11/02/2021, Thursday
AA
BioNTech, Turkey in talks on opening research center in country

Industry minister says BioNTech's Ugur Sahin wants to work on cancer research in Turkey, continues to talk with authorities

German-based BioNTech is in talks with Turkey to set up a research center in the country, the Turkish industry and technology minister told Anadolu Agency on Wednesday.

Reklam yükleniyor...

Reklam yükleniyor...

Ugur Sahin, the Turkish-German co-founder of BioNTech, “wants to work on cancer research in Turkey, and continues to negotiate with the authorities to build a center," said Mustafa Varank.

"We discussed with Sahin what can be done in Turkey apart from vaccine development work. He’s preparing his plans now and wants to set up a cancer research center here."

Sahin and Hasan Mandal, head of the Scientific and Technological Research Council of Turkey (TUBITAK), have been in talks as far back as last April, Varank said.

Relevant institutions told Sahin about both public and private sector capabilities, Varank said and added:

"We proposed joint vaccine production to them. It's at the heart of the agenda. We will be pleased to welcome them and be home their center in Turkey."

Underlining that global firms have been heavily investing in RD, Varank said if Sahin comes to Turkey his work will benefit from the contributions that Turkey has to offer.

- Turkish vaccines to begin human trials

In an update of Turkey’s work to develop a coronavirus vaccine, he said it currently has three vaccine candidates – inactive, VLP and adenovirus-based – ready to begin human trials.

"We have completed all the necessary studies of these three vaccines and submitted our intermediate results to the Health Ministry," he added.

Varank also said the government is currently negotiating with countries, bringing proposals to countries with very large populations to do Phase 3 studies together.

"We’re currently negotiating with them to see if we can do joint production," he added.

On the local vaccine candidates, Varank said: "I am a candidate to be a volunteer, I’ve already registered. I call on Turkish citizens to join forces and contribute to scientific research."

Turkey has drugs in the works that would both prevent the spread of the virus and be used to treat it, the minister added.

Reklam yükleniyor...

Reklam yükleniyor...

Comments
user

Comments you share on our site are a valuable resource for other users. Please be respectful of different opinions and other users. Avoid using rude, aggressive, derogatory, or discriminatory language.

Turkey's Accumulation. International Media Group.

Welcome to the news source that sets Turkey's agenda! With its impartial, dynamic, and in-depth journalism, Yeni Şafak offers its readers an experience beyond current events. Get instant updates on what's happening in Turkey and worldwide, with news spanning a wide range from politics and economy to culture, arts, and sports. Access the most accurate information anytime, anywhere with its digital platforms; keep up with the agenda with Yeni Şafak!

Follow us on social media.
Download Mobile Apps

Carry the agenda in your pocket! With Yeni Şafak's mobile apps, get instant access to the latest news. A wide range of content, from politics to economy, sports to culture and arts, is at your fingertips! Easily download it on your iOS, Android, and Huawei devices to quickly access the most accurate information anytime, anywhere. Download now, don't miss out on developments around the world!

Categories
Albayrak Media

Maltepe Mah. Fetih Cad. No:6 34010 Zeytinburnu/İstanbul, Türkiyeiletisim@yenisafak.com+90 212 467 6515

LEGAL DISCLAIMER

The BIST name and logo are protected under a 'Protection Trademark Certificate' and cannot be used, quoted, or modified without permission. All information disclosed under the BIST name is fully copyrighted by BIST and may not be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.

© Net Medya, All right reserved. 2025